Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LOC102723831 (ENSG00000223598) is an uncharacterized antisense long non-coding RNA (lncRNA) transcript located antisense to the MTHFD1L gene. As a transcript of unknown coding potential, and as no protein product or biological function has been described, its role in physiology or disease is currently unclear. There is no evidence that the transcript itself acts as a therapeutic target, nor have drugs, disease roles, or biomarkers been associated with it. The related sense gene, MTHFD1L, encodes a mitochondrial enzyme involved in one-carbon metabolism and folate cycling, essential for nucleotide biosynthesis and cellular methylation processes[5][7][4][1]. Some disease relevance for the *sense* gene (MTHFD1L), such as association with neural tube defects, exists, but this does not apply to the antisense transcript, which is currently annotated as "uncharacterized" in gene databases and appears to be only a predicted or poorly studied RNA without known function or clinical significance[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uncharacterized transcript antisense to MTHFD1L (ENSG00000223598).